drugset / Trial / NCT00200746
Treatment of Alcohol-Related Hepatitis With Arginine
Phase 2
Withdrawn
National Center for Complementary and Integrative Health (NCCIH)
Office of Dietary Supplements (ODS) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test the effectiveness of the amino acid arginine in reducing liver injury in individuals with alcohol-related hepatitis.
Timeline
- Start
- 2006-04
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-arginine | Small molecule | 1 % | — |
| Subject | L-arginine | Small molecule | 2 % | — |
| Subject | L-arginine | Small molecule | 6 % | — |